Tue, October 13, 2020

Matthew Harrison Maintained (ADCT) at Buy with Decreased Target to $52 on, Oct 13th, 2020

Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $53 to $52 on, Oct 13th, 2020.

Matthew, nor any peers, have made any analyst calls on ADCT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30